In sepsis models involving both standard and multidrug-resistant bacteria, these peptides alleviated tissue pathology by repressing pro-inflammatory mediators (TNF-α, IL-1β) and augmenting anti-inflammatory responses driven by IL-10, TGF-β, and lipoxins. The gene discussed is TNF; the disease is Sepsis.